Target intelligence / Profile preview

Acidic leucine-rich nuclear phosphoprotein 32 family member E (ANP32E)

Target
ANP32E
Molecular classification
Histone chaperone, Chromatin regulator, Protein phosphatase inhibitor
01

Overview

Acidic leucine-rich nuclear phosphoprotein 32 family member E (ANP32E) is a small, evolutionarily conserved nuclear protein characterized by an N-terminal leucine-rich repeat domain and a C-terminal acidic region[2][5]. Its principal function is as a histone chaperone, particularly for H2A.Z, facilitating the removal of H2A.Z from chromatin and stabilizing the H2A.Z-H2B dimer in the cytoplasm and nucleoplasm[1][3][4][6]. Unlike classical chromatin remodelers, ANP32E is not a stable component of major chromatin remodeling complexes but acts to buffer and stabilize soluble H2A.Z in a cell cycle-dependent manner, ensuring proper nuclear import and chromatin incorporation of H2A.Z[3][4]. ANP32E also inhibits protein phosphatase 2A (PP2A) activity and may participate in apoptotic regulation and intracellular transport pathways[2][6]. Dysregulation of ANP32E has been implicated in cancer cell proliferation, with context-dependent roles that may be oncogenic[3][5]. No drugs, biomarkers, or safety data are currently documented for direct targeting of ANP32E as a therapeutic target.

Other names
Acidic nuclear phosphoprotein 32 family member EANP32EAcidic leucine-rich nuclear phosphoprotein 32 family member ELANP-LLANPLMGC5350LANP-like proteinLeucine-rich acidic nuclear protein like
02

Biological functions

Chromatin modification and remodelingHistone chaperone (removal and stabilization of H2A.Z)Apoptosis regulation (caspase modulation)Protein phosphatase 2A inhibitionIntracellular transport
03

Disease associations

Cancer (proliferation and possible oncogene activity)Neurodevelopmental processes (cerebellar development)
04

Safety considerations

Potential context-dependent role in cancer (oncogenic or tumor suppressor function may vary)[3][5]

Beyond the preview

Go deeper on Acidic leucine-rich nuclear phosphoprotein 32 family member E (ANP32E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acidic leucine-rich nuclear phosphoprotein 32 family member E (ANP32E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call